Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Amyloidosis

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Amyloidosis in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, H1
Zhao, J1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Amyloidosis

ArticleYear
Disruption of the Golgi apparatus mediates zinc deficiency-induced impairment of cognitive function in mice.
    Metallomics : integrated biometal science, 2019, 12-11, Volume: 11, Issue:12

    Topics: Amyloidosis; Animals; Chelating Agents; Cognition; Ethylenediamines; Golgi Apparatus; Golgi Matrix P

2019